These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 17325032

  • 1. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.
    Flügel D, Görlach A, Michiels C, Kietzmann T.
    Mol Cell Biol; 2007 May; 27(9):3253-65. PubMed ID: 17325032
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription.
    Ampofo E, Kietzmann T, Zimmer A, Jakupovic M, Montenarh M, Götz C.
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1729-35. PubMed ID: 20637892
    [Abstract] [Full Text] [Related]

  • 3. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA, Ashcroft M.
    Cancer Res; 2006 Jun 15; 66(12):6264-70. PubMed ID: 16778202
    [Abstract] [Full Text] [Related]

  • 4. Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells.
    Ader I, Brizuela L, Bouquerel P, Malavaud B, Cuvillier O.
    Cancer Res; 2008 Oct 15; 68(20):8635-42. PubMed ID: 18922940
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 6. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C, Moore JW, Robertson N, Harris AL.
    Cancer Res; 2001 Oct 01; 61(19):7349-55. PubMed ID: 11585776
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma.
    Gao YH, Li CX, Shen SM, Li H, Chen GQ, Wei Q, Wang LS.
    Biochem Biophys Res Commun; 2013 May 24; 435(1):46-51. PubMed ID: 23611775
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system.
    Ni J, Ni A.
    PLoS One; 2021 May 24; 16(7):e0248019. PubMed ID: 34329303
    [Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.
    Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J.
    Mol Cell Biol; 2006 Mar 24; 26(6):2019-28. PubMed ID: 16507982
    [Abstract] [Full Text] [Related]

  • 10. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
    Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ.
    Cancer Res; 2005 Jun 01; 65(11):4775-81. PubMed ID: 15930297
    [Abstract] [Full Text] [Related]

  • 11. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
    Foxler DE, Bridge KS, James V, Webb TM, Mee M, Wong SC, Feng Y, Constantin-Teodosiu D, Petursdottir TE, Bjornsson J, Ingvarsson S, Ratcliffe PJ, Longmore GD, Sharp TV.
    Nat Cell Biol; 2012 Jan 29; 14(2):201-8. PubMed ID: 22286099
    [Abstract] [Full Text] [Related]

  • 12. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.
    Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C.
    J Biol Chem; 2003 Aug 15; 278(33):31277-85. PubMed ID: 12764143
    [Abstract] [Full Text] [Related]

  • 13. AG490 promotes HIF-1α accumulation by inhibiting its hydroxylation.
    Fernández-Sánchez R, Berzal S, Sánchez-Niño MD, Neria F, Gonçalves S, Calabia O, Tejedor A, Calzada MJ, Caramelo C, Deudero JJ, Ortiz A.
    Curr Med Chem; 2012 Aug 15; 19(23):4014-23. PubMed ID: 22709000
    [Abstract] [Full Text] [Related]

  • 14. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
    Kalakech H, Tamareille S, Pons S, Godin-Ribuot D, Carmeliet P, Furber A, Martin V, Berdeaux A, Ghaleh B, Prunier F.
    J Mol Cell Cardiol; 2013 Dec 15; 65():98-104. PubMed ID: 24140799
    [Abstract] [Full Text] [Related]

  • 15. Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity.
    Park MH, Bae SS, Choi KY, Min do S.
    Exp Mol Med; 2015 Nov 27; 47(11):e196. PubMed ID: 26611735
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K, Makino Y, Pereira T, Poellinger L.
    EMBO J; 2000 Aug 15; 19(16):4298-309. PubMed ID: 10944113
    [Abstract] [Full Text] [Related]

  • 17. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.
    Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL.
    Mol Cell; 2007 Jan 26; 25(2):207-17. PubMed ID: 17244529
    [Abstract] [Full Text] [Related]

  • 18. Role of the von Hippel-Lindau tumour suppressor protein in the regulation of HIF-1alpha and its oxygen-regulated transactivation domains at high cell density.
    Paltoglou SM, Roberts BJ.
    Oncogene; 2005 May 26; 24(23):3830-5. PubMed ID: 15750626
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions.
    Jung YS, Lee SJ, Yoon MH, Ha NC, Park BJ.
    Cell Cycle; 2012 Dec 01; 11(23):4462-73. PubMed ID: 23159849
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the glycogen synthase kinase 3β-hypoxia-inducible factor 1α pathway alleviates NLRP3-mediated pyroptosis induced by high glucose in renal tubular epithelial cells.
    Wan J, Jiang Z, Liu D, Pan S, Zhou S, Liu Z.
    Exp Physiol; 2022 Dec 01; 107(12):1493-1506. PubMed ID: 36056793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.